Patent details

Herbas

VPB

Print

EN | LT

LT - TOFACITINIB ORAL SUSTAINED RELEASE DOSAGE FORMS

EN - TOFACITINIB ORAL SUSTAINED RELEASE DOSAGE FORMS

Legal status

Patent not validated

Bibliographic data

Indications of the International Patent Classification (IPC)
(51)	INT.CL.	A61K 9/28
		A61K 9/48
		A61K 31/519
		A61P 1/04
		A61P 17/06
		A61P 19/02
		A61P 37/06

European patent
(11)	Number of the document	2968155
(13)	Kind of document	T
(96)	European patent application number	14726410.5
	Date of filing the European patent application	2014-03-12
(97)	Date of publication of the European application	2016-01-20
(45)	Date of publication and mention of the grant of the patent	2021-03-03
(46)	Date of publication of the claims translation

PCT application
(86)	Number	PCT/IB2014/059689
	Date	2014-03-12

PCT application publication
(87)	Number	WO 2014/147526
	Date	2014-09-25

Priority applications
(30)	Number	Date	Country code
	201361802479 P	2013-03-16	US
	201361864059 P	2013-08-09	US
	201461934428 P	2014-01-31	US

Inventors
(72)	HERBIG, Scott Max, US KRISHNASWAMI, Sriram, US KUSHNER IV, Joseph, US LAMBA, Manisha, US STOCK, Thomas C., US

Grantee
(73)	Pfizer Inc., 235 East 42nd Street, New York, NY 10017, US

Title
(54)	TOFACITINIB ORAL SUSTAINED RELEASE DOSAGE FORMS
	TOFACITINIB ORAL SUSTAINED RELEASE DOSAGE FORMS